Latest News
Latest News and Events
- All
- Events
- Featured
- Imspex Clinical
- Imspex Industrial
Hepatocellular carcinoma urinary biomarker detection using GC-IMS
Taking breath analysis into the future
A patent for our technology
Breath analysis for COVID-19 screening
Breath analysis using BreathSpec®
Breath analysis to detect COVID-19
New times, new technology
Emerging Tech Fest 2021
IMSPEX Diagnostics and National Physical Laboratory (NPL) collaborate on Siloxane analysis
VOCs In New Car Interiors
Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer
BBC exposure for BreathSpec system

Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th

Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is

Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic

TOXI- Triage
In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency

TOXI – Triage – DISPERSE exercise
On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a

Leicester publication highlights Imspex and GC-IMS
Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and











